Skip to main content
. 2010 Dec 26;4(1):43–52.

Table 2.

Classification of patients by risk group and presence of NAAD

Risk Group NAAD Total P
No Yes
IR 9 (56.2%) 7 (43.7%) 16 (41.0%) 0.407
HR 15 (65.2%) 8 (34.8%) 23 (59.0%) 0.740
Total 24 (61.5%) 15 (38.5) 39 (100.0%)

NAAD: neoadjuvant androgen deprivation; IR: intermediate risk for biochemical failure; HR: high risk for biochemical failure.